Condition : Joint Diseases Interventions : Device: Total Hip Replacement; Device: Total hip replacement Sponsor : DePuy Orthopaedics Completed - verified August 2011

Condition : Early Rheumatoid Arthritis Interventions : Biological: Adalimumab; Drug: Methotrexate; Biological: Adalimumab placebo; Drug: Methotrexate placebo Sponsor : Abbott Active, not recruiting -...

Condition : Joint Diseases Interventions : Device: Total Hip Replacement; Device: Total hip replacement Sponsor : DePuy Orthopaedics Completed - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Biological: Adalimumab; Biological: Adalimumab; Drug: Placebo; Biological: Adalimumab; Biological: Adalimumab; Biological: Adalimumab Sponsor : Abbott...

Condition : Osteoarthrosis Intervention : Device: Bimetric femoral stem Sponsor : Northern Orthopaedic Division, Denmark Completed - verified August 2011

Condition : Osteoarthrosis Intervention : Device: Bimetric femoral stem Sponsor : Northern Orthopaedic Division, Denmark Completed - verified August 2011

Condition : Coxarthrosis Interventions : Device: porous coated Trilogy®; Device: Trilogy Calcicoat® Sponsor : Northern Orthopaedic Division, Denmark Completed - verified August 2011

Condition : Gout Interventions : Drug: Placebo; Drug: Febuxostat; Drug: Febuxostat; Drug: Febuxostat Sponsor : Takeda Global Research & Development Center, Inc. Completed - verified July 2011

Condition : Coxarthrosis Interventions : Device: porous coated Trilogy®; Device: Trilogy Calcicoat® Sponsor : Northern Orthopaedic Division, Denmark Completed - verified August 2011

Condition : Rheumatoid Arthritis Intervention : Biological: Certolizumab pegol (CDP870) Sponsor : UCB, Inc. Active, not recruiting - verified February 2011